Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Depreciation and Depletion: 2010-2024

Historic Depreciation and Depletion for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $5.0 million.

  • Anika Therapeutics' Depreciation and Depletion rose 7.69% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is 2.04% up from last year.
  • Per Anika Therapeutics' latest filing, its Depreciation and Depletion stood at $5.0 million for FY2024, which was up 2.04% from $4.9 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Depreciation and Depletion registered a high of $6.5 million during FY2021, and its lowest value of $4.9 million during FY2022.
  • For the 3-year period, Anika Therapeutics' Depreciation and Depletion averaged around $4.9 million, with its median value being $4.9 million (2023).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first increased by 22.00% in 2020, then decreased by 24.62% in 2022.
  • Anika Therapeutics' Depreciation and Depletion (Yearly) stood at $6.1 million in 2020, then increased by 6.56% to $6.5 million in 2021, then fell by 24.62% to $4.9 million in 2022, then remained steady at $4.9 million in 2023, then increased by 2.04% to $5.0 million in 2024.